{"log_id": 5122503390219508566, "direction": 0, "words_result_num": 20, "words_result": [{"probability": {"variance": 0.002461, "average": 0.986993, "min": 0.700999}, "location": {"width": 812, "top": 194, "height": 39, "left": 230}, "words": "E3174不影响其它激素受体或心血管中重要的离子通道的功能,也不抑制降解"}, {"probability": {"variance": 0.004899, "average": 0.976357, "min": 0.645274}, "location": {"width": 811, "top": 241, "height": 38, "left": 231}, "words": "缓激肽的血管紧张素转化酶(激肽酶I)。因此,不会出现缓激肽作用增强导致"}, {"probability": {"variance": 2e-06, "average": 0.999111, "min": 0.996102}, "location": {"width": 115, "top": 298, "height": 26, "left": 233}, "words": "的不良反应"}, {"probability": {"variance": 0.000294, "average": 0.99542, "min": 0.900466}, "location": {"width": 766, "top": 333, "height": 41, "left": 278}, "words": "阿利沙坦酯与氯沙坦钾相比,代谢途径相对简单,不会产生氯沙坦钾经肝"}, {"probability": {"variance": 5e-05, "average": 0.997327, "min": 0.962174}, "location": {"width": 632, "top": 382, "height": 38, "left": 233}, "words": "脏代谢产生的多种与降压疗效无关的其它代谢产物(见图2)"}, {"probability": {"variance": 0, "average": 0.337358, "min": 0.337358}, "location": {"width": 129, "top": 463, "height": 126, "left": 372}, "words": " RE3"}, {"probability": {"variance": 0, "average": 0.995469, "min": 0.995469}, "location": {"width": 88, "top": 536, "height": 84, "left": 490}, "words": "/"}, {"probability": {"variance": 0.138158, "average": 0.737171, "min": 0.211514}, "location": {"width": 357, "top": 786, "height": 122, "left": 331}, "words": "=%"}, {"probability": {"variance": 0, "average": 0.989116, "min": 0.989116}, "location": {"width": 24, "top": 984, "height": 23, "left": 1182}, "words": "令"}, {"probability": {"variance": 0.002338, "average": 0.917373, "min": 0.869021}, "location": {"width": 106, "top": 1018, "height": 34, "left": 932}, "words": "药业"}, {"probability": {"variance": 0.0006, "average": 0.985985, "min": 0.921829}, "location": {"width": 517, "top": 1080, "height": 69, "left": 489}, "words": "图2阿利沙坦酯与氯沙坦钾的代谢产物比较"}, {"probability": {"variance": 0, "average": 0.99962, "min": 0.999071}, "location": {"width": 97, "top": 1178, "height": 29, "left": 237}, "words": "毒理研究"}, {"probability": {"variance": 0, "average": 0.999749, "min": 0.999225}, "location": {"width": 95, "top": 1227, "height": 27, "left": 283}, "words": "遗传毒性"}, {"probability": {"variance": 0.000855, "average": 0.991083, "min": 0.82957}, "location": {"width": 765, "top": 1269, "height": 31, "left": 283}, "words": "阿利沙坦酯Ames试验、CHL细胞染色体畸变试验、小鼠微核试验结果均"}, {"probability": {"variance": 0, "average": 0.999891, "min": 0.999757}, "location": {"width": 72, "top": 1320, "height": 28, "left": 240}, "words": "为阴性"}, {"probability": {"variance": 0, "average": 0.999705, "min": 0.99901}, "location": {"width": 99, "top": 1367, "height": 29, "left": 285}, "words": "生殖毒性"}, {"probability": {"variance": 0.00277, "average": 0.987781, "min": 0.675093}, "location": {"width": 763, "top": 1408, "height": 32, "left": 286}, "words": "大鼠经口给予阿利沙坦酯30-270mg/kg,未见对生育力的明显影响。妊娠"}, {"probability": {"variance": 0.005946, "average": 0.97772, "min": 0.623404}, "location": {"width": 811, "top": 1457, "height": 31, "left": 238}, "words": "大鼠和家兔经口给予阿利沙坦酯分别30—270mg/kg和15--35mgkg,高剂量"}, {"probability": {"variance": 9.6e-05, "average": 0.996297, "min": 0.939804}, "location": {"width": 809, "top": 1503, "height": 31, "left": 239}, "words": "组下可见胚胎胎仔生长发育毒性,安全剂量分别为90mgkg和<45mg/kg。大鼠"}, {"probability": {"variance": 0.003606, "average": 0.94348, "min": 0.859761}, "location": {"width": 35, "top": 1582, "height": 20, "left": 638}, "words": "/11"}], "language": 3}